The second is phosphorylase b kinase regulatory subunit beta (Phkb; Kpbb), which stimulates glycogen breakdown58, and predicts poor prognosis in human hepatocellular carcinoma patients when downregulated, whereas it inhibits cell proliferation and induces apoptosis of tumor cells when artificially upregulated59. This evidence concerns the gene PHKB and hepatocellular carcinoma.